Interleukin-2 Signaling via STAT5 Constrains T Helper 17 Cell Generation

Immunity

Volumn 26, Issue 3, 2007, Pages 371-381

  Laurence, Arian ^a   Tato, Cristina M ^a   Davidson, Todd S ^b   Kanno, Yuka ^a   Chen, Zhi ^a   Yao, Zhengju ^a   Blank, Rebecca B ^b   Meylan, Françoise ^a   Siegel, Richard ^a   Hennighausen, Lothar ^c   Shevach, Ethan M ^b   O'Shea, John J ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

CELLIMMUNO; MOLIMMUNO; SIGNALING

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 2; STAT5 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DEATH; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE DELETION; HELPER CELL; INFLAMMATORY DISEASE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; INTERLEUKIN-17; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MICE; MICE, MUTANT STRAINS; STAT3 TRANSCRIPTION FACTOR; STAT5 TRANSCRIPTION FACTOR; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 33947162110     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2007.02.009     Document Type: Article

References (42)

1. Abbas A.K. The control of T cell activation vs. tolerance. Autoimmun. Rev. 2 (2003) 115-118
2. Abbas A.K., Murphy K.M., and Sher A. Functional diversity of helper T lymphocytes. Nature 383 (1996) 787-793
3. Aggarwal S., Ghilardi N., Xie M.H., de Sauvage F.J., and Gurney A.L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278 (2003) 1910-1914
4. Antov A., Yang L., Vig M., Baltimore D., and Van Parijs L. Essential role for STAT5 signaling in CD25+CD4+ regulatory T cell homeostasis and the maintenance of self-tolerance. J. Immunol. 171 (2003) 3435-3441
5. Astoul E., Laurence A.D., Totty N., Beer S., Alexander D.R., and Cantrell D.A. Approaches to define antigen receptor-induced serine kinase signal transduction pathways. J. Biol. Chem. 278 (2003) 9267-9275
6. Batten M., Li J., Yi S., Kljavin N.M., Danilenko D.M., Lucas S., Lee J., de Sauvage F.J., and Ghilardi N. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat. Immunol. 7 (2006) 929-936
7. Beadling C., Guschin D., Witthuhn B.A., Ziemiecki A., Ihle J.N., Kerr I.M., and Cantrell D.A. Activation of JAK kinases and STAT proteins by interleukin-2 and interferon alpha, but not the T cell antigen receptor, in human T lymphocytes. EMBO J. 13 (1994) 5605-5615
8. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., Weiner H.L., and Kuchroo V.K. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441 (2006) 235-238
9. Chen Z., Laurence A., Kanno Y., Pacher-Zavisin M., Zhu B.M., Tato C., Yoshimura A., Hennighausen L., and O'Shea J.J. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc. Natl. Acad. Sci. USA 103 (2006) 8137-8142
10. Cua D.J., Sherlock J., Chen Y., Murphy C.A., Joyce B., Seymour B., Lucian L., To W., Kwan S., Churakova T., et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421 (2003) 744-748
11. Cui Y., Riedlinger G., Miyoshi K., Tang W., Li C., Deng C.X., Robinson G.W., and Hennighausen L. Inactivation of STAT5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation. Mol. Cell. Biol. 24 (2004) 8037-8047
12. Flavell R.A. The molecular basis of T cell differentiation. Immunol. Res. 19 (1999) 159-168
13. Glimcher L.H. Lineage commitment in lymphocytes: controlling the immune response. J. Clin. Invest. 108 (2001) s25-s30
14. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., and Weaver C.T. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6 (2005) 1123-1132
15. Ivanov I.I., McKenzie B.S., Zhou L., Tadokoro C.E., Lepelley A., Lafaille J.J., Cua D.J., and Littman D.R. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17(+) T helper cells. Cell 126 (2006) 1121-1133
16. Johnston J.A., Wang L.M., Hanson E.P., Sun X.J., White M.F., Oakes S.A., Pierce J.H., and O'Shea J.J. Interleukins 2, 4, 7, and 15 stimulate tyrosine phosphorylation of insulin receptor substrates 1 and 2 in T cells. Potential role of JAK kinases. J. Biol. Chem. 270 (1995) 28527-28530
17. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., McClanahan T., Kastelein R.A., and Cua D.J. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201 (2005) 233-240
18. Lee J.Y., and Hennighausen L. The transcription factor STAT3 is dispensable for pancreatic beta-cell development and function. Biochem. Biophys. Res. Commun. 334 (2005) 764-768
19. Lee C.K., Raz R., Gimeno R., Gertner R., Wistinghausen B., Takeshita K., DePinho R.A., and Levy D.E. STAT3 is a negative regulator of granulopoiesis but is not required for G-CSF-dependent differentiation. Immunity 17 (2002) 63-72
20. Li M.O., Sanjabi S., and Flavell R.A. Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 25 (2006) 455-471
21. Malek T.R. The main function of IL-2 is to promote the development of T regulatory cells. J. Leukoc. Biol. 74 (2003) 961-965
22. Mangan P.R., Harrington L.E., O'Quinn D.B., Helms W.S., Bullard D.C., Elson C.O., Hatton R.D., Wahl S.M., Schoeb T.R., and Weaver C.T. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441 (2006) 231-234
23. Marie J.C., Liggitt D., and Rudensky A.Y. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor. Immunity 25 (2006) 441-454
24. McKarns S.C., Schwartz R.H., and Kaminski N.E. Smad3 is essential for TGF-beta 1 to suppress IL-2 production and TCR-induced proliferation, but not IL-2-induced proliferation. J. Immunol. 172 (2004) 4275-4284
25. McKenzie B.S., Kastelein R.A., and Cua D.J. Understanding the IL-23-IL-17 immune pathway. Trends Immunol. 27 (2006) 17-23
26. Mosmann T.R., and Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7 (1989) 145-173
27. Murphy K.M., and Reiner S.L. The lineage decisions of helper T cells. Nat. Rev. Immunol. 2 (2002) 933-944
28. Murphy C.A., Langrish C.L., Chen Y., Blumenschein W., McClanahan T., Kastelein R.A., Sedgwick J.D., and Cua D.J. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198 (2003) 1951-1957
29. Refaeli Y., and Abbas A.K. Role of cytokines in autoimmunity. Eur. Cytokine Netw. 9 (1998) 81-82
30. Refaeli Y., Van Parijs L., and Abbas A.K. Genetic models of abnormal apoptosis in lymphocytes. Immunol. Rev. 169 (1999) 273-282
31. Shevach E.M., DiPaolo R.A., Andersson J., Zhao D.M., Stephens G.L., and Thornton A.M. The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells. Immunol. Rev. 212 (2006) 60-73
32. Snow J.W., Abraham N., Ma M.C., Herndier B.G., Pastuszak A.W., and Goldsmith M.A. Loss of tolerance and autoimmunity affecting multiple organs in STAT5A/5B-deficient mice. J. Immunol. 171 (2003) 5042-5050
33. Strober W., Ludviksson B.R., and Fuss I.J. The pathogenesis of mucosal inflammation in murine models of inflammatory bowel disease and Crohn disease. Ann. Intern. Med. 128 (1998) 848-856
34. Stumhofer J.S., Laurence A., Wilson E.H., Huang E., Tato C.M., Johnson L.M., Villarino A.V., Huang Q., Yoshimura A., Sehy D., et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 7 (2006) 937-945
35. Suzuki H., Kundig T.M., Furlonger C., Wakeham A., Timms E., Matsuyama T., Schmits R., Simard J.J., Ohashi P.S., Griesser H., et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 268 (1995) 1472-1476
36. Thornton A.M., and Shevach E.M. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188 (1998) 287-296
37. Umetsu D.T., McIntire J.J., Akbari O., Macaubas C., and DeKruyff R.H. Asthma: an epidemic of dysregulated immunity. Nat. Immunol. 3 (2002) 715-720
38. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., and Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24 (2006) 179-189
39. Veldhoen M., Hocking R.J., Flavell R.A., and Stockinger B. Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat. Immunol. 7 (2006) 1151-1156
40. Yao Z., Cui Y., Watford W.T., Bream J.H., Yamaoka K., Hissong B.D., Li D., Durum S.K., Jiang Q., Bhandoola A., et al. STAT5a/b are essential for normal lymphoid development and differentiation. Proc. Natl. Acad. Sci. USA 103 (2006) 1000-1005
41. Yao Z., Kanno Y., Kerenyi M., Stephens G., Durant L., Watford W.T., Laurence A., Robinson G.W., Shevach E.M., Morrigl R., et al. Nonredundant roles for STAT5a/b in directly regulating Foxp3. Blood Press (2007) 10.1182/blood-2006-11-055756 Published online January 16, 2007
42. Ye P., Rodriguez F.H., Kanaly S., Stocking K.L., Schurr J., Schwarzenberger P., Oliver P., Huang W., Zhang P., Zhang J., et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 194 (2001) 519-527